Gerard Vondeling

Vice President of Global Market Access & Value Evidence @ Valneva

Country

Austria

City

Vienna

Industry

Pharmaceuticals

Skill

Health Economics, Health Technology Assessment, Pharmacoeconomics, Market Access, Oncology, Real World Evidence (RWE), Real World Data (RWD), Patient Reported Outcomes, Outcomes Research, Pricing Strategy, Vaccines

Experience

Vice President of Global Market Access & Value Evidence

Valneva

2024-5 - Present · 2 yrs 5 mos

Vienna, Austria

Head of Global Market Access & Value Evidence

Valneva

2021-7 - 2024-5 · 2 yrs 11 mos

Vienna, Austria

Director Global HEOR & Real World Evidence

Daiichi Sankyo Europe GmbH

2019-10 - 2021-7 · 1 yr 10 mos

München en omgeving, Duitsland

Responsible for the development and implementation of HEOR strategy encompassing the generation and dissemination of value evidence for successful market access for Daiichi Sankyo’s Oncology Solid Tumor portfolio.

Senior Manager Global HEOR

Daiichi Sankyo Europe GmbH

2018-10 - 2019-10 · 1 yr 1 mo

München en omgeving, Duitsland

Responsible for the development and implementation of HEOR strategy encompassing the generation and dissemination of value evidence for successful market access for Daiichi Sankyo’s products.

PhD-candidate

University of Groningen

2016-12 - 2021-7 · 4 yrs 8 mos

Groningen, Nederland

External PhD candidate in Health Economics and Outcome Research with focus on Orphan drugs and Oncology. Experienced in decision modeling for health economic evaluation.